CoChat

Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: Opportunities, challenges and future directions for cerebral stroke management

Rana, Anil Kumar, Singh, Damanpreet · 2018 · Neuropharmacology
Cited by 98

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Cerebral stroke is a leading cause of early death and physical disability in adults throughout the world. Oxidative stress and inflammation plays an important role in the pathological process associated with the stroke. The available reperfusion therapy itself enhances the oxidative stress by overproduction of reactive oxygen species (ROS) and reactive nitrogen species (RNS) from the neurons, as well as non‐neuronal cells, thus further worsens the condition. Excessive ROS and RNS production contributes to the brain injury during or after the stroke by activating inflammatory processes. Glycogen synthase kinase‐3 (Gsk‐3) is an evolutionary conserved serine‐threonine kinase that plays an important role in cellular growth, development, inflammation and apoptosis processes. Gsk‐3 is activated during the brain stroke and suppresses the expression of nuclear factor‐E2‐related factor 2, an important regulator of endogenous antioxidant defence mechanism. It also modulates the expression of anti‐inflammatory protein like, cAMP response element binding protein and activator protein 1. It has been found that the inhibition of Gsk‐3 shows neuroprotection via reducing the oxidative stress and inflammation in cerebral ischemia/reperfusion. The present review describes in depth the role of oxidative stress, neuroinflammatory processes and endogenous defence systems involved in cerebral stroke pathogenesis, and their regulation by Gsk‐3. Further the reports of all the potential agents modulating Gsk‐3 activity via different signalling pathways have been summarized to substantiate its effectiveness in cerebral stroke management. HIGHLIGHTSGsk‐3 plays an integral role in cerebral stroke pathogenesis.Oxidative stress during ischemia modulates the Gsk‐3 activity.Nrf2 expression is altered following Gsk‐3 activation.Activated Gsk‐3 enhances neuro inflammatory processes.Gsk‐3 inhibition can be a potential therapy for management of cerebral stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2018.07.006

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 98

Metadata

Authors
Rana, A. K., & Singh, D.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2018-09
Volume
139
Pages
124-136
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2829515097
Cited by
98
References
29
FWCI
7.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: Opportunities, challenges and future directions for cerebral stroke management. https://app.cochat.ai/papers/10.1016/j.neuropharm.2018.07.006
The paper
Rana, A. K., & Singh, D. (2018). Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: Opportunities, challenges and future directions for cerebral stroke management. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2018.07.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.